Bumetanide
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume - Medicaid only, not all-payer.
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Glenmark Pharmaceuticals Inc., USA | generic | 2 | SUPPLYING |
| Novadoz Pharmaceuticals LLC | generic | 2 | SUPPLYING |
| Civica, Inc | unknown | 2 | SUPPLYING |
| Fresenius Kabi, USA LLC | generic | 2 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | generic | 2 | SUPPLYING |
| Mullan Pharmaceutical Inc. | unknown | 2 | SUPPLYING |
| Qilu Pharmaceutical Co. Ltd. | unknown | 2 | SUPPLYING |
| Camber Pharmaceuticals, Inc. | generic | 2 | SUPPLYING |
| Lupin Pharmaceuticals,Inc. | generic | 2 | SUPPLYING |
| Bryant Ranch Prepack | repackager | 2 | SUPPLYING |
| Cardinal Health 107, LLC | repackager | 2 | SUPPLYING |
| Gland Pharma Limited | generic | 2 | SUPPLYING |
| HF Acquisition Co. LLC, DBA HealthFirst | repackager | 1 | SUPPLYING |
Shortages, recalls, and registration changes attached to this drug concept.
Bumetanide Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Cardiovascular.
Bumetanide Injection — reported in shortage by MSN Laboratories Private Limited. Therapeutic category: Cardiovascular.
Bumetanide Injection — reported in shortage by Mullan Pharmaceutical Inc.. Therapeutic category: Cardiovascular.
